期刊
PHYTOTHERAPY RESEARCH
卷 36, 期 3, 页码 1156-1181出版社
WILEY
DOI: 10.1002/ptr.7389
关键词
cancer; curcumin; nanoformulations
资金
- Vice-Chancellor for Research at Tabriz University of Medical Sciences [63939]
Curcumin, a phytochemical derived from turmeric, is widely used for cancer treatment. However, its efficacy is limited due to issues like rapid metabolism, low bioavailability, and toxicity. Scientists have explored novel drug delivery systems to overcome these problems.
Curcumin is a phytochemical achieved from the plant turmeric. It is extensively utilized for the treatment of several types of diseases such as cancers. Nevertheless, its efficiency has been limited because of rapid metabolism, low bioavailability, poor water solubility, and systemic elimination. Scientists have tried to solve these problems by exploring novel drug delivery systems such as lipid-based nanoparticles (NPs) (e.g., solid lipid NPs, nanostructured lipid carriers, and liposomes), polymeric NPs, micelles, nanogels, cyclodextrin, gold, and mesoporous silica NPs. Among these, liposomes have been the most expansively studied. This review mainly focuses on the different curcumin nanoformulations and their use in cancer therapy in vitro, in vivo, and clinical studies. Despite the development of curcumin-containing NPs for the treatment of cancer, potentially serious side effects, including interactions with other drugs, some toxicity aspects of NPs may occur that require more high-quality investigations to firmly establish the clinical efficacy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据